Bankole Una entrevista de Johnson fue

Same author

Validation of serotonin transporter mRNA as a quantitative biomarker of heavy drinking and its comparison to ethyl glucuronide/ethyl sulfate: A randomized, double-blind, crossover trial.

Alcoholism, clinical and experimental research·2022

Same author

A randomized, double-blind, placebo-controlled trial of ondansetron for the treatment of cocaine use disorder with post hoc pharmacogenetic analysis.

Drug and alcohol dependence·2021

Same author

The Maudsley's obsessional children: phenomenology, classification, and associated neurobiological and co-morbid features.

European child & adolescent psychiatry·2018

Same author

FDA and EMA Need Homology on Alcohol Outcome Measures-Semper: Simplicitas est purius modum.

Alcoholism, clinical and experimental research·2017

Same author

Toward Rational, Evidence-Based, and Clinically Relevant Measures to Determine Improvement Following Treatment for Alcohol Use Disorder.

Alcoholism, clinical and experimental research·2017

Same author

A Phase 2, Double-Blind, Placebo-Controlled Randomized Trial Assessing the Efficacy of ABT-436, a Novel V1b Receptor Antagonist, for Alcohol Dependence.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2016

Videos de Experimentos Relacionados

Bankole Una entrevista de Johnson fue

Videos de Conceptos Relacionados

Validation of serotonin transporter mRNA as a quantitative biomarker of heavy drinking and its comparison to ethyl glucuronide/ethyl sulfate: A randomized, double-blind, crossover trial.

A randomized, double-blind, placebo-controlled trial of ondansetron for the treatment of cocaine use disorder with post hoc pharmacogenetic analysis.

The Maudsley's obsessional children: phenomenology, classification, and associated neurobiological and co-morbid features.

FDA and EMA Need Homology on Alcohol Outcome Measures-Semper: Simplicitas est purius modum.

Toward Rational, Evidence-Based, and Clinically Relevant Measures to Determine Improvement Following Treatment for Alcohol Use Disorder.

A Phase 2, Double-Blind, Placebo-Controlled Randomized Trial Assessing the Efficacy of ABT-436, a Novel V1b Receptor Antagonist, for Alcohol Dependence.

Videos de Experimentos Relacionados

Bankole Una entrevista de Johnson fue

Videos de Conceptos Relacionados

Validation of serotonin transporter mRNA as a quantitative biomarker of heavy drinking and its comparison to ethyl glucuronide/ethyl sulfate: A randomized, double-blind, crossover trial.

A randomized, double-blind, placebo-controlled trial of ondansetron for the treatment of cocaine use disorder with post hoc pharmacogenetic analysis.

The Maudsley's obsessional children: phenomenology, classification, and associated neurobiological and co-morbid features.

FDA and EMA Need Homology on Alcohol Outcome Measures-Semper: Simplicitas est purius modum.

Toward Rational, Evidence-Based, and Clinically Relevant Measures to Determine Improvement Following Treatment for Alcohol Use Disorder.

A Phase 2, Double-Blind, Placebo-Controlled Randomized Trial Assessing the Efficacy of ABT-436, a Novel V1b Receptor Antagonist, for Alcohol Dependence.

Videos de Experimentos Relacionados

Bankole Una entrevista de Johnson fue

Videos de Conceptos Relacionados

Artículos Relacionados

Validation of serotonin transporter mRNA as a quantitative biomarker of heavy drinking and its comparison to ethyl glucuronide/ethyl sulfate: A randomized, double-blind, crossover trial.

A randomized, double-blind, placebo-controlled trial of ondansetron for the treatment of cocaine use disorder with post hoc pharmacogenetic analysis.

The Maudsley's obsessional children: phenomenology, classification, and associated neurobiological and co-morbid features.

FDA and EMA Need Homology on Alcohol Outcome Measures-Semper: Simplicitas est purius modum.

Toward Rational, Evidence-Based, and Clinically Relevant Measures to Determine Improvement Following Treatment for Alcohol Use Disorder.

A Phase 2, Double-Blind, Placebo-Controlled Randomized Trial Assessing the Efficacy of ABT-436, a Novel V1b Receptor Antagonist, for Alcohol Dependence.

Videos de Experimentos Relacionados

Bankole Una entrevista de Johnson fue

Videos de Conceptos Relacionados

Artículos Relacionados

Validation of serotonin transporter mRNA as a quantitative biomarker of heavy drinking and its comparison to ethyl glucuronide/ethyl sulfate: A randomized, double-blind, crossover trial.

A randomized, double-blind, placebo-controlled trial of ondansetron for the treatment of cocaine use disorder with post hoc pharmacogenetic analysis.

The Maudsley's obsessional children: phenomenology, classification, and associated neurobiological and co-morbid features.

FDA and EMA Need Homology on Alcohol Outcome Measures-Semper: Simplicitas est purius modum.

Toward Rational, Evidence-Based, and Clinically Relevant Measures to Determine Improvement Following Treatment for Alcohol Use Disorder.

A Phase 2, Double-Blind, Placebo-Controlled Randomized Trial Assessing the Efficacy of ABT-436, a Novel V1b Receptor Antagonist, for Alcohol Dependence.